Fasting-mimicking diet plus combination therapy for kidney cancer
Treatments studied
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a special low-calorie diet (fasting-mimicking diet) combined with two types of medicine (immunotherapy and targeted therapy) for people with advanced kidney cancer. The diet might help the medicines work better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have advanced or spreading kidney cancer with clear cell type (confirmed by biopsy).
- You must not have had any prior treatment for kidney cancer (except for some older immune treatments).
- You must have a body mass index (BMI) of 20 or higher.
- You must be generally active (able to do light work) and have adequate organ function (liver, kidney, heart, and blood counts).
- You must be willing to follow a special 5-day fasting-mimicking diet and stay in contact with the study team during that time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, PF-08634404, alone or with other cancer treatments, for adults with advanced kidney cancer that has not been treated before. It aims to see if the drug can help shrink tumors or stop them from growing.
This study combines a special periodic diet that mimics fasting with the standard immunotherapy drug pembrolizumab (Keytruda) for people with advanced non-small cell lung cancer. The goal is to see if the diet can help the immunotherapy work better.
This trial tests whether adding a special low-calorie diet (called a fasting-mimicking diet) to standard chemotherapy and immunotherapy can help treat triple-negative breast cancer before surgery. It aims to see if this combination makes the treatment work better.
This trial tests whether a special low-calorie diet, called a fasting-mimicking diet, can make chemotherapy work better for advanced ovarian cancer. The diet is designed to mimic the effects of fasting while still providing some nutrition, and may help reduce side effects or improve treatment response.
This trial tests whether an intermittent, fasting-like diet can help control metastatic prostate cancer and improve metabolic health in men on hormone therapy. Participants follow a specific diet plan and are monitored by the study team.
This trial tests whether adding a cholesterol-lowering drug (atorvastatin) to the standard combination of two cancer drugs (axitinib and toripalimab) can improve outcomes for people with advanced clear cell kidney cancer that cannot be removed by surgery or has spread. The goal is to see if this three-drug approach is safe and effective.
Hear when a new Metastatic Renal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.